☆ 4.5 Article

MFAP2 promotes HSCs activation through FBN1/TGF-β/Smad3 pathway

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

Fibrillin-1 and asprosin, novel players in metabolic syndrome

Kim M. Summers et al.

Summary: Fibrillin-1 serves as a component of extracellular microfibrils and plays a role in connective tissues' elasticity. It has been found that a peptide derived from fibrillin-1, called asprosin, functions as a glucogenic hormone during fasting and stimulates appetite in the hypothalamus. Asprosin levels are associated with metabolic syndrome-related pathologies. The relationship between the generation of asprosin and the expression of fibrillin-1 protein needs further exploration.

MOLECULAR GENETICS AND METABOLISM (2023)

Add to Collection

Article Gastroenterology & Hepatology

Testicular orphan receptor 4 induced hepatic stellate cells activation via the regulation of TGF-fl receptor I/Smad2/3 signaling pathway

Yadong Fu et al.

Summary: This study aimed to investigate the role of testicular orphan receptor 4 (TR4) in the activation of hepatic stellate cells (HSCs) and found that TR4 may promote liver fibrosis by regulating the TflRI/Smad2/3 and RXRa signaling pathways.

ANNALS OF HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation

Haoye Zhang et al.

Summary: GLIS2 deficiency promotes myofibroblastic transdifferentiation and activation of hepatic stellate cells (HSCs). Mechanically, GLIS2 regulates the acetylation of PPAR-gamma by competitively binding to HDAC3 in HSCs.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis

Marcos F. Fondevila et al.

Summary: We found that the expression of CPT1A is elevated in HSCs of patients with fibrosis, and that CPT1A induces the activation of these cells. Inhibition of CPT1A can ameliorate fibrosis by preventing the activation of HSCs.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Medicine, Research & Experimental

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management

Eslam E. Abd El-Fattah et al.

Summary: This article discusses the impact of heat shock proteins HSP70 and HSP47 on liver fibrosis, with HSP70 reducing protein aggregation and HSP47 promoting collagen synthesis. Additionally, the article explores potential therapeutic approaches targeting HSP70 and HSP47 as drug candidates for treating liver fibrosis.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Cell Biology

Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis

Bowen Li et al.

Summary: Liver fibrosis is a complex process that is regulated by neuroendocrine factors. The interaction between neuroendocrine hormones and their receptors forms a complicated network that controls hepatic inflammation and the progression of liver fibrosis.

CELLS (2022)

Add to Collection

Article Immunology

Igf2bp2 knockdown improves CCl4-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1

Zhenyu Xu et al.

Summary: Progressive liver fibrosis is a dynamic process characterized by the accumulation of ECM, with Igf2bp2 and Tgfbr1 playing crucial roles. Knockdown of Igf2bp2 can improve liver fibrosis by targeting Tgfbr1, possibly through the PI3K/Akt pathway.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease

Yujia Li et al.

Summary: Transforming growth factor-beta (TGF-beta) is an important factor in the liver that plays a role in various processes initiated by liver injury. It affects different types of liver cells and the response depends on the specific context. In the healthy liver, TGF-beta is stored in the extracellular matrix as latent TGF-beta (L-TGF-beta), and the protein ECM1 is critical for maintaining its latency. Activation of L-TGF-beta has detrimental effects on liver structure and function. This review article presents current knowledge on the formation, secretion, matrix deposition, and activation of L-TGF-beta, and highlights the potential therapeutic benefits of reducing L-TGF-beta activation in liver fibrosis and liver cancer.

JHEP REPORTS (2022)

Add to Collection

Review Cell Biology

Molecular structure and function of microfibrillar-associated proteins in skeletal and metabolic disorders and cancers

Sipin Zhu et al.

Summary: MFAPs are a group of extracellular matrix glycoproteins, consisting of five subfamily members, with each member having distinct features and discrete purposes. Among them, MFAP2-deficient mice exhibit progressive osteopenia, MFAP5-deficient mice are neutropenic, and MFAP4-deficient mice displayed emphysema-like pathology and the impaired formation of neointimal hyperplasia. Emerging data also suggest that MFAPs are involved in cancer progression and fat metabolism.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Add to Collection

Review Cell Biology

The Power of Plasticity?Metabolic Regulation of Hepatic Stellate Cells

Parth Trivedi et al.

Summary: Hepatic stellate cells play a crucial role in regulating physiological and pathological responses in the liver, particularly in chronic liver injury. They drive hepatic fibrosis and are involved in inflammation and cancer by adapting metabolic pathways to meet increased energy demands.

CELL METABOLISM (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Decreased Levels of Microfibril-Associated Glycoprotein (MAGP)-1 in Patients with Colon Cancer and Obesity Are Associated with Changes in Extracellular Matrix Remodelling

Iranzu Gomez de Segura et al.

Summary: Obesity and colon cancer significantly decreased MFAP2 gene expression levels in VAT, while an opposite trend was observed in TGFB1 mRNA levels. Stimulation of HT-29 cells with LPS and IL-4 increased MFAP2 mRNA levels, while treatment with CoCl2 led to downregulation. MAGP-1 treatment enhanced the expression of ECM-remodelling genes and reduced the expression levels of COX2/PTGS2 in CC cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Fibrillin-1-enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease

Li Li et al.

Summary: This study demonstrates the crucial role of FBN1 in mediating vascular rarefaction in CKD by orchestrating a hostile microenvironment for endothelial cells. The upregulation of FBN1 in fibrotic kidney tissue was found in animal models and patients, leading to apoptosis and inhibition of proliferation in endothelial cells. RNA sequencing identified the activated integrin alpha(v)beta(6)/transforming growth factor-beta signaling as the key pathway in FBN1-induced endothelial injury, and blocking this pathway ameliorated renal fibrosis and vascular rarefaction in a mouse model of CKD.

SCIENCE ADVANCES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice

Yasuhiro Nakano et al.

HEPATOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of the growth factor?binding sequence in the extracellular matrix protein MAGP-1

Thomas J. Broekelmann et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Pro-Fibrotic Phenotype in a Patient with Segmental Stiff Skin Syndrome via TGF-β Signaling Overactivation

Carmela Fusco et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer

Si Yang Dong et al.

CANCER MANAGEMENT AND RESEARCH (2020)

Add to Collection

Review Cell Biology

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019

Bedair Dewidar et al.

CELLS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Microfibril-associated glycoproteins MAGP-1 and MAGP-2 in disease

Clarissa S. Craft et al.

MATRIX BIOLOGY (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

MFAP2 promotes epithelial-mesenchymal transition in gastric cancer cells by activating TGF-β/SMAD2/3 signaling pathway

Jian-Kai Wang et al.

ONCOTARGETS AND THERAPY (2018)

Add to Collection

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Characterization of transcriptional modules related to fibrosing-NAFLD progression

Yi Lou et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Cell Biology

TGF-/SMAD Pathway and Its Regulation in Hepatic Fibrosis

Fengyun Xu et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Characterization of metabolic health in mouse models of fibrillin-1 perturbation

Tezin A. Walji et al.

MATRIX BIOLOGY (2016)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Hepatology Snapshot: Mechanisms of liver fibrosis resolution

Frank Tacke et al.

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Editorial Material Endocrinology & Metabolism

MAGP1, the extracellular matrix, and metabolism

Clarissa S. Craft

ADIPOCYTE (2015)

Add to Collection

Article Endocrinology & Metabolism

The Extracellular Matrix Protein MAGP1 Supports Thermogenesis and Protects Against Obesity and Diabetes Through Regulation of TGF-β

Clarissa S. Craft et al.

DIABETES (2014)

Add to Collection

Article Cell Biology

Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung

Outi Lepparanta et al.

CELL AND TISSUE RESEARCH (2012)

Add to Collection

Review Pathology

Pathogenesis of Liver Fibrosis

Virginia Hernandez-Gea et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Add to Collection

Review Gastroenterology & Hepatology

Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies

Yury Popov et al.

HEPATOLOGY (2009)

Add to Collection

Article Genetics & Heredity

Searching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries

Nelson J. F. Silveira et al.

BMC MEDICAL GENOMICS (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Deficiency in microfibril-associated glycoprotein-1 leads to complex phenotypes in multiple organ systems

Justin S. Weinbaum et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Add to Collection

Article Hematology

Functional analysis of zebrafish microfibril-associated glycoprotein-1 (Magp 1) in vivo reveals roles for microfibrils in vascular development and function

Eleanor Chen et al.

BLOOD (2006)

Add to Collection

Article Gastroenterology & Hepatology

The role of Smad3 in mediating mouse hepatic stellate cell activation

B Schnabl et al.

HEPATOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.